Key result
A 58-year-old man with stage IVa thymoma developed fatal giant cell myocarditis and polymyositis following a second cycle of chemotherapy with carboplatin and paclitaxel.
Population
58-year-old male with stage IVa type B2 thymoma, positive acetylcholine receptor binding antibody titers…
Design
Case_report
Follow-up
9 days in hospital
Authors
Loading...
Fatal myocarditis may occur after carboplatin-paclitaxel in thymoma; leaves open causal link and requires prospective study before practice implications.
Case Report (n=1)
This case report highlights the rare but fatal occurrence of giant cell myocarditis and polymyositis in a patient with thymoma following chemotherapy with carboplatin and paclitaxel.
Sasaki et al. (2011) conducted a case report in Stage IVa type B2 thymoma (n=1). Carboplatin and paclitaxel was evaluated on Development of fatal myocarditis and polymyositis. A 58-year-old man with stage IVa thymoma developed fatal giant cell myocarditis and polymyositis following a second cycle of chemotherapy with carboplatin and paclitaxel.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: